• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

A Prospective Study to Measure Pulmonary Artery Hypertension Using Two-Dimensional Echocardiography in Thyroid Dysfunction

    Dr. Manish Kumar, Dr. Archana Verma

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 800-805

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: To evaluate the two-dimensional echocardiographic assessment of pulmonary artery hypertension in thyroid dysfunction.
Methods: A prospective double blind randomized controlled study was conducted at ARC Hospital, Bhagalpur, Bihar, India for 1 year. Thyroid function tests were done in all cases using Enzyme immunoassay to confirm the presence of hypo or hyperthyroidism. Electrocardiography was recorded in all the patients. Chest X-rays were done and examined for roentgenographic signs of pulmonary hypertension, i.e. right descending pulmonary artery diameter of >1.5 cm. 2D-Echocardiography was done in all cases and screened for the presence and severity of pulmonary hypertension.
Results: In our study out of the 100 cases, 70(70%) cases were of Hypothyroidism and 30 (30%) cases were of Hyperthyroidism. Unpaired t test is applied. P value is significant if < 0.05 PASP value in patients with hyperthyroidism was 31.06mm Hg while that in the patients with hypothyroidism was 27.17mm Hg. Difference between them was comparable. 80% patients with hypothyroidism and 66.66% patients with hyperthyroidism had normal PASP level. While 20% patients with hyperthyroidism had mild and moderate PASP each, only 16.67% with hypothyroidism had mild PASP. The mean PASP by Doppler Echocardiography was 39.52 mm of Hg in the pre-treatment group. And the mean PASP during the follow up (after 10 months) was 31 mm of Hg. Among the patients in the Hypothyroidism group with PAH, the pre-treatment values of TSH and PASP were high and reduced in the follow-up (after 10 months of treatment) Among the patients in the Hyperthyroidism group with PAH, the mean pre-treatment value of TSH was 0.2 and increased to 2.35 in the follow up. Mean PASP value was 42.6 and reduced in the follow-up (after 10 months of treatment) to 31.7.
Conclusion: The PAH secondary to thyroid dysfunctions may be reversed by restoration of euthyroid state, and hence patients have a good prognosis if diagnosed and treated timely. So every patient of thyroid dysfunction should be screened for PAH, even though further studies are needed to substantiate this.
Keywords:
  • PDF (186 K)
  • XML
(2021). A Prospective Study to Measure Pulmonary Artery Hypertension Using Two-Dimensional Echocardiography in Thyroid Dysfunction. European Journal of Molecular & Clinical Medicine, 8(4), 800-805.
Dr. Manish Kumar, Dr. Archana Verma. "A Prospective Study to Measure Pulmonary Artery Hypertension Using Two-Dimensional Echocardiography in Thyroid Dysfunction". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 800-805.
(2021). 'A Prospective Study to Measure Pulmonary Artery Hypertension Using Two-Dimensional Echocardiography in Thyroid Dysfunction', European Journal of Molecular & Clinical Medicine, 8(4), pp. 800-805.
A Prospective Study to Measure Pulmonary Artery Hypertension Using Two-Dimensional Echocardiography in Thyroid Dysfunction. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 800-805.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 137
  • PDF Download: 195
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus